Highlights
-
• Sierra Leone, Guinea, and Liberia are highly endemic for HBV; yet, childhood vaccination coverage remains suboptimal.
-
• The HBV vaccination coverage from recent national surveys was 70.3% in Sierra Leone, 64.5% in Liberia, and 40.0% in Guinea.
-
• Predictors of incomplete vaccination included Muslim mothers, lower household wealth index, <4 antenatal visits, home delivery, and distance to health facilities.
-
• Addressing socioeconomic and healthcare access barriers is essential for achieving the 2030 viral hepatitis elimination goals.
Introduction
The global burden of hepatitis B virus (HBV) remains a major public health and developmental challenge. According to World Health Organization (WHO) estimates, there were 296 million chronic cases of HBV worldwide in 2021 [1]. Sub-Saharan Africa (SSA) is disproportionately impacted by the HBV epidemic – about 6.1% of the population live with chronic HBV infection, which accounts for approximately 20% of the global burden [1]. In SSA, the HBV infection is most commonly acquired through vertical transmission or horizontally through close contact during early childhood [1, Reference Keane, Funk and Shimakawa2]. In response to the global problem of HBV, the Global Health Sector Strategy [3] and the Sustainable Development Goals [4] have endorsed the elimination of HBV as a public health threat by the year 2030.
The most effective method of preventing HBV is through vaccination [4]. Timely administration of the HBV birth dose vaccine given within the first 24 h of life followed by an additional 2 or 3 doses is 98%–100% effective at preventing mother-to-child transmission (MTCT) and has been instrumental in reducing the incidence of the HBV infection globally [1, Reference Zanetti, Van Damme and Shouval5]. The WHO and other international guidelines recommend universal HBV screening of pregnant women and vaccination of all non-immune newborns and adults [6–8]. However, in many countries in SSA, the HBV vaccine is not given at birth but is administered as part of the pentavalent vaccine (HBV, diphtheria, tetanus, pertussis, and Haemophilus influenzae type B) at 6, 10, and 14 weeks post-partum [Reference Breakwell9]. Despite this, vaccination coverage has remained low in many SSA countries. Several factors have contributed to the low coverage rates, including inadequate immunization programme funding, fragile health systems, and limited knowledge of the risks of HBV infection and the benefits of vaccination [Reference Breakwell9–Reference Sonderup11]. Thus, understanding and addressing modifiable determinants of suboptimal vaccination will be crucial to meeting the HBV elimination goals.
Sierra Leone, Liberia, and Guinea are neighbouring West African countries with similar cultural, socioeconomic, and demographic characteristics. Guinea is the most populous of the three countries (15.5 million), while Sierra Leone and Liberia had population estimates of 8.14 million and 5.18 million in 2021, respectively [12]. Furthermore, the three countries share a recent history of civil warfare (1990–2001) and new public health challenges, including the largest Ebola outbreak in history (2014–2016) – all of which have aligned to further weaken the already fragile local healthcare systems [Reference Shoman, Karafillakis and Rawaf13, Reference Kassa, Scarf and Fox14]. Additionally, all three countries are grappling with major HBV epidemics. According to recent estimates, the national prevalence of chronic HBV cases was 13.0% in Sierra Leone [Reference Yendewa15], 13.5% in Liberia [16], and 11.7% in Guinea [16], indicating hyperendemic levels of HBV infection in all three countries. Guinea initiated childhood HBV vaccination in 2006, followed by Sierra Leone in 2007 and Liberia in 2008 [Reference Breakwell9]; however, the HBV birth dose vaccine has not been introduced into the childhood immunization schedule and all three countries are yet to implement national HBV control policies due to limited resources and other constraints [Reference Breakwell9].
Prevention of MTCT of HBV through HBV vaccination is essential to achieve the viral hepatitis elimination goals in Sierra Leone, Guinea, and Liberia. However, there is a paucity of studies assessing HBV vaccination coverage rates and barriers to the uptake of HBV vaccination in the population. To better inform vaccination strategies in Sierra Leone, Liberia, and Guinea, we used recent national survey data from the three countries to estimate national HBV vaccination coverage levels. Furthermore, we explored sociodemographic, economic, and healthcare factors serving as potential barriers to HBV vaccination in the three West African countries.
Methods
Conceptual framework
Our conceptual framework was guided by the Strategic framework for research on immunization in the WHO African Region ― Immunization and Vaccine Development by the WHO [17] and other relevant literature that have described facilitators and barriers to childhood vaccination in low- and middle-income countries [Reference González-Lorenzo18]. These frameworks outline crucial objectives, such as enhancing vaccine safety and efficacy, promoting research and development of new vaccines, strengthening immunization programmes, improving vaccine supply and delivery, and increasing community engagement and demand for vaccination services [17, Reference González-Lorenzo18]. Facilitators and barriers that have been strongly associated with vaccination coverage include lack of knowledge and awareness among the population, vaccine hesitancy, inadequate health infrastructure and human resources, social and cultural factors, and limited access to vaccines and vaccination services [17, Reference González-Lorenzo18]. For the purpose of our study, our modified conceptual framework proposes that childhood HBV vaccination uptake in Sierra Leone, Liberia, and Guinea is determined by sociodemographic and economic factors either directly or through the mediation of other factors such as healthcare access, health behaviours, and access to information (Figure 1). Understanding these factors is the first essential step towards crafting evidence-based policy aimed at improving vaccination coverage and ultimately lessening the burden of HBV and other vaccine-preventable diseases in this setting.
Figure 1. Conceptual framework of complete HBV immunization Arrows represents a causal link.
Survey methodology
We conducted a secondary analysis of data from the most recent Demographic and Health Surveys (DHS) carried out in Sierra Leone (2019), Liberia (2019–2020), and Guinea (2018). DHS are nationally representative cross-sectional surveys that are regularly conducted in over 90 developing countries to provide information on key population and health indicators. More information on sampling methods and data collection procedures are described in detail in the individual country DHS reports [19–21]. Briefly, the surveys employed a stratified, two-stage cluster probability sampling design and utilized the latest country census sampling frame to identify strata. To ensure representativeness, the size of strata was allocated non-probabilistically, with larger strata ‘under-sampled’ while smaller strata were ‘over-sampled’. Within each stratum, census enumeration areas were then selected as the primary sampling units in proportion to size. Finally, a fixed number of households were selected within the enumeration areas using equal probability systematic sampling. All women aged 15–49 years who permanently resided at or slept in a selected household on the night prior to the survey were eligible to participate. Consenting participants were interviewed using a standardized women’s questionnaire. The interview response rates were > 98% in all three countries [19–21].
Measures
The primary outcome variables were ‘complete hepatitis B vaccination coverage’ and ‘incomplete hepatitis B vaccination coverage’ among children aged 4–35 months in Sierra Leone, Liberia, and Guinea, respectively. During DHS, information on routine childhood vaccination was collected by asking eligible mothers about the vaccination status of their child (the index case) in the three years preceding the survey. Information on vaccination was provided in two ways: (1) written vaccination records or health cards and (2) verbal reports. The responses provided were recorded as follows: ‘no’, ‘vaccination date on card’, ‘vaccination marked on card’, ‘reported by mother’, and ‘don’t know’. To estimate hepatitis B vaccination coverage for each of the 3 recommended doses, we assessed the responses recorded under the variables ‘received pentavalent 1’, ‘received pentavalent 2’, and ‘received pentavalent 3’, respectively, given that hepatitis B vaccination is administered as the pentavalent vaccine in Sierra Leone, Liberia, and Guinea. The overall coverage for each of the 3 recommended doses was estimated by summing all 3 affirmative responses, i.e. ‘vaccination date on card’, ‘vaccination marked on card’, and ‘reported by mother’. Thus, the primary outcome of ‘complete hepatitis B immunization’ was defined as having received all 3 doses of the pentavalent vaccine as reported under the variable ‘received pentavalent 3’. ‘Incomplete hepatitis B immunization’ was defined as having missed at least 1 of the 3 recommended doses and was a composite of the responses ‘no’ and ‘don’t know’ recorded under the variable ‘received pentavalent 3’. We excluded children aged <4 months from the analysis as the third dose of the pentavalent vaccine is administered at 14 weeks.
Where necessary, we recoded variables. The explanatory variables for incomplete HBV vaccination included sex of the child (male vs. female), mother’s relationship status (recoded as ‘single’ vs. ‘married’), religion (recoded ‘Christian’ vs. ‘Muslim’), educational level (recoded as ‘no education’ vs. ‘primary or higher’), type of place of residence (urban vs. rural), and country region. The effect of adolescent motherhood on vaccination coverage was assessed as a binary variable (recoded as ‘15–19 years’ vs. ≥ ‘20 years’). Household wealth index was recoded as a binary variable ‘poor’ (poorest and poorer quintiles) vs. ‘rich’ (middle, richer, and richest quintiles). The number of antenatal visits was recoded as a binary variable (‘0–3’ vs. ‘≥4’) in accordance with the WHO recommendation of a minimum of 4 antenatal visits for favourable pregnancy outcomes [22]. Parity was similarly recoded as a binary variable (‘1–4’ vs. ‘5’) in accordance with current regional fertility rates reported by DHS from each country [19–21]. We assessed the effect of healthcare access on vaccination coverage using the variables ‘money for treatment’ (‘big problem’ vs. ‘not a big problem’) and ‘distance to health facility’ (‘big problem’ vs. ‘not a big problem’). We recoded the variable ‘place of delivery’ as ‘home’ vs. ‘health facility’. Finally, we assessed access to mass media as a source of health information on vaccination coverage using the variables ‘exposure to radio’, ‘exposure to television’, and ‘exposure to internet’ (recoded as ‘yes’ vs. ‘no’, respectively).
Statistical analyses
We used the complex command package of SPSS Version 28.0 (IBM Corp, NY, USA) to perform statistical analyses, taking into account the complex two-stage cluster sampling design and weighting. Sociodemographic and health characteristics were reported using summary statistics. Categorical variables were expressed as unweighted frequencies (weighted percentages), and vaccination coverage estimates were presented as percentages with 95% confidence intervals (CI). We used the Pearson chi-square test to evaluate differences between characteristics. To identify factors associated with incomplete hepatitis B immunization, we employed logistic regression. In the final multivariable logistic regression model, only explanatory variables with p < 0.20 in the univariate analysis were included, with statistical significance set at p < 0.05 for all analyses and presented crude odds ratios and adjusted odds ratios (aOR) with 95% CI. Furthermore, we found no evidence of collinearity among explanatory variables (Supplementary Material, available on the Cambridge Core website).
Ethical approval
The protocols for the DHS methodology and data collection procedures were approved by the institutional review boards or ethics committees at ICF Macro, the Sierra Leone Ethics and Scientific Review Committee, the University of Liberia Pacific Institute for Research and Evaluation, and the Guinea National Ethics Committee for Health Research (Comité National d’Ethique pour la Recherche en Santé). Written permission to use the respective country datasets was granted by DHS.
Results
Characteristics of survey respondents
Of a total of 11,181 mothers included in the analysis, 4,846 were from Sierra Leone, 2,788 from Liberia, and 3,547 were from Guinea (Table 1). The children were aged 4–35 months, and the ratio of males to females was roughly 1:1 across countries. A minority of respondents were adolescent mothers and single (Table 1). Guinea had the highest proportion of mothers with no education (73.2%), compared with Sierra Leone (51.6%) and Liberia (33.5%) (p < 0.001). The majority of respondents were Muslim in Sierra Leone (79.6%) and Guinea (87.9%), whereas in Liberia Christians formed the majority (82.5%). Roughly half (52.9%) of the households selected in Liberia were in urban areas, whereas in Sierra Leone and Guinea about two-thirds of households were in rural areas. In each country, an equal proportion of households were selected across wealth quintiles.
Table 1. Baseline sociodemographic and health characteristics of index child and households by country
Regarding health-seeking and healthcare access, mothers in Sierra Leone and Liberia had better health indicators in comparison to Guinea. More mothers in Sierra Leone (74.1%) and Liberia (81.4%) accessed antenatal care services 4 or more times during pregnancy, while in Guinea antenatal care attendance was low (33.7%). Similarly, a higher proportion of mothers from Guinea reported delivery at home (43.6%), compared to 14.0% and 16.3% in Sierra Leone and Liberia, respectively. A larger proportion of respondents from Sierra Leone considered money for healthcare payments and distance to healthcare facilities a greater problem compared to the other two countries. On the other hand, information through mass media (radio/television) was more accessible in Guinea, while internet access was more widely available in Liberia.
Complete hepatitis B vaccination coverage by respondent characteristics
Table 2 shows complete hepatitis B vaccination coverage by respondent sociodemographic and health characteristics. Sierra Leone had the highest overall vaccination coverage at 70.3% (95% CI 68.5–72) and Liberia at 64.6% (95% CI 61.3–68.0), while Guinea had the lowest overall vaccination coverage at 39.3% (95% CI 36.3–42.4). There were variations in vaccination coverage within and between countries based on sociodemographic and healthcare access (Table 2). In Sierra Leone, older mothers, Christians, those delivering at private facilities, and those near healthcare facilities had significantly higher coverage. In Liberia, male children, wealthier households, ≥ 4 antenatal visits, and government health centre deliveries had higher coverage. Guinea’s vaccination coverage varied by factors like education, wealth, urban residence, ≥ 4 antenatal visits, government hospital deliveries, and internet access (Table 2).
Table 2. Complete HBV immunization coverage rates overall and by sociodemographic and health characteristics
a Complete HBV immunization coverage was defined as completing all 3 series of vaccines administered at 6, 10, and 14 weeks after birth and was estimated as a composite of ‘vaccination date on card’, ‘vaccination marked on card’, and ‘reported by mother’ (Table 1).
Predictors of incomplete hepatitis B vaccination
Tables 3 and 4 display the results of univariate and multivariate regression analyses of factors associated with incomplete hepatitis B vaccination coverage. In Sierra Leone, being an adolescent mother (aOR 1.36, 95% CI 1.05–1.75), being a Muslim (aOR 1.28, 95% CI 1.03–1.59), lower wealth index (aOR 1.20, 95% CI 1.00–1.43), and distance to health facility (aOR 1.20, 95% CI 1.01–1.43) were associated with higher odds of incomplete immunization, while being a female child was associated with lower odds of incomplete vaccination (aOR 0.86, 95% CI 0.74–0.99). In contrast, in Liberia, female children (aOR 1.83, 95% CI 1.30–2.59), less than 4 antenatal visits (aOR 1.83, 95% CI 1.30–2.59), and home delivery (aOR 1.48, 95% CI 1.02–2.13) were significantly associated with incomplete immunization. Similarly, in Guinea, healthcare factors were the dominant predictors of incomplete immunization, i.e. <4 antenatal visits (aOR 2.31, 95% CI 1.87–2.85) and home delivery (aOR 2.18, 95% CI 1.74–2.74). Additionally, in Guinea, being a Muslim (aOR 1.96, 95% CI 1.28–2.99) and being a resident in the Labé region (aOR 2.58, 95% CI 1.49–4.48) were significantly associated with incomplete immunization.
Table 3. Univariate analysis of factors associated with incomplete HBV immunization a
a Incomplete HBV immunization was a composite variable defined as completing 0, 1, or 2 of the recommended 3 HBV vaccine doses administered at 6, 10, and 14 weeks after birth.
Table 4. Multivariate analysis of factors associated with incomplete HBV immunizationª
a Incomplete HBV immunization was a composite variable defined as completing 0, 1, or 2 of the recommended 3 HBV vaccine doses administered at 6, 10, and 14 weeks after birth.
Discussion
To the best of our knowledge, this is the first population-based study to estimate national hepatitis B vaccination coverage rates and identify factors associated with incomplete HBV vaccination among children in Sierra Leone, Liberia, and Guinea, three West African countries with a high burden of HBV infection. Sierra Leone had the highest national vaccination coverage at 70.3%, while Liberia and Guinea had lower coverage rates at 64.7% and 40%, respectively. Our estimates were slightly lower than coverage rates compiled jointly by WHO and the United Nation’s Children’s Emergency Fund (WHO/UNICEF), which reported a 95% vaccination coverage rate for Sierra Leone in 2019, 70% for Liberia in 2020, and 47% for Guinea in 2018 [23]. Furthermore, the coverage rates from our study were lower than those reported by other West African countries such as Senegal (93%), the Gambia (88%), Burkina Faso (91%), and Mali (77%) [23]. The differences in vaccination coverage among the three countries could be attributed to various factors, including sociocultural and healthcare service-related factors, as well as variations in the data sources used to calculate the estimates. The WHO/UNICEF estimates relied on both administrative data from healthcare providers and population-based surveys and focussed on children aged 12–35 months [23]. In contrast, our estimates were solely based on population-based surveys and included younger children aged 4–35 months, who were more likely to lag in completing the vaccine series [19–21].
Annually, around 820,000 people die from complications of chronic HBV infection worldwide [1]. In many endemic countries in SSA, there are still entrenched disparities and inequities in access to quality healthcare including HBV screening, treatment, and prevention services, despite the availability of an effective HBV vaccine since 1982 and the WHO’s call for the global elimination of viral hepatitis as a public health threat by 2030 [4]. In our examination of disparities in HBV vaccination coverage based on key sociodemographic, economic, and healthcare access factors, we identified significant intra- and intercountry differences in vaccination coverage. Of the factors examined, higher rates of vaccination coverage were observed for facility-based delivery in Liberia and Guinea. Other factors that were associated with higher vaccination coverage in more than one country were antenatal care visits, higher household wealth quintiles, fewer births, religion (Christianity), and within proximity to a healthcare facility. In Guinea, higher maternal level of education, access to information through mass media, and payments for health services were additional factors that were associated with vaccination coverage. Similar findings have been observed in other African countries [Reference Mbengue24–Reference Bbaale27].
Furthermore, we assessed independent predictors of incomplete vaccination coverage. Healthcare access indices predominated as were the most important factors. Children born to mothers who had fewer than four antenatal care visits had 1.83- to 2.3-fold higher odds of not completing vaccination in Liberia and Guinea. Similarly, home delivery was significantly associated with incomplete vaccination coverage in the two countries. In contrast, in Sierra Leone, children with mothers who considered distance to health facilities a ‘big problem’ were significantly less likely to complete the vaccination series. These findings are not surprising, as antenatal care attendance and delivery in healthcare facility provide opportunities for educating mothers on the benefits of vaccination and other vital maternal and child health services [Reference Jani28]. Taken together, our findings are in agreement with others who have suggested that HBV infection is fundamentally a disease of poverty [Reference O’Hara29, Reference Martyn30]; thus, HBV control efforts should aim to address socioeconomic inequities to achieve elimination targets [Reference Breakwell9, Reference O’Hara29, Reference Martyn30].
Another notable finding was the observed impact of religion on HBV vaccination uptake. Children of Muslim mothers were less likely to complete the HBV vaccination series in Sierra Leone and Guinea, which have majority Muslim populations. Studies from elsewhere corroborate these findings. A recent systematic review from the United Kingdom found that being Muslim played a role in parents’ decision-making about routine childhood vaccination [Reference Forster31]. However, these findings warrant more careful interpretation, as there is no conclusive evidence to suggest that Muslims are less likely to vaccinate compared with people of other religious or cultural backgrounds. For example, a study from Malaysia found that the majority of Muslim parents surveyed had positive attitudes towards childhood immunizations and believed that vaccines were permissible under Islamic law (or ‘Sharia’) [Reference Ansari32]. In contrast, studies have found that Evangelical Christians in the United States [Reference Corcoran, Scheitle and Digregorio33] and in Nigeria [Reference Wonodi34] have been the most hesitant to vaccinate against coronavirus-19 compared with other religious groups. Overall, these findings suggest that vaccine acceptance is a complex issue that is influenced by a multitude of factors, including level of education, access to healthcare, trust in healthcare providers, and cultural, religious, and political beliefs [Reference Forster31–Reference Wonodi34]. To improve vaccine uptake among all communities, it is important to address concerns and provide accurate information about vaccine safety and efficacy.
Our study did not directly assess the impact of the HBV birth dose vaccination on HBV vaccine completion rates as it has not been implemented in any of the three countries that were examined. However, the HBV birth dose vaccination is an important factor to consider when examining the suboptimal coverage rates observed in our study. The WHO has reported that as of 2021, only 14 of the 47 countries in the WHO African region have integrated the HBV birth dose vaccine into their national immunization programmes and about 1 in 5 newborns in this region receive the birth dose vaccine [35]. In addition to preventing the MTCT of HBV, multiple studies, mostly from high-income settings, have shown that timely administration of the HBV birth dose vaccine is associated with 1.8- to 3-fold higher completion rates of the three-dose HBV vaccine series, as well as other routine childhood vaccines [Reference Wangen, Zhu and Wang36–Reference Oster38]. In the few countries in SSA where the HBV birth dose has been implemented, impact assessment studies have highlighted barriers such as implementation cost, a high proportion of births taking place outside of health facilities (e.g. home births), limited access to skilled birth attendants, and inadequate knowledge of HBV among health workers and parents as major factors limiting the successful implementation of the birth dose vaccination [35, Reference Oster38–Reference Oku40]. Thus, effective implementation of the HBV birth dose vaccination in SSA requires a comprehensive approach that addresses health system strengthening, awareness-raising, delivery platforms, vaccine supply chain management, and multisectoral collaboration and partnership. By extension, successful implementation of these strategies can enhance HBV vaccination coverage overall and reduce the burden of HBV infection in SSA.
It is important to acknowledge the limitations of our study, which can impact the generalizability of our findings. These pertain to the use of secondary data sources, potential recall biases in data collection, challenges in determining causal links, and under-sampling of certain populations. To address some of these limitations, it would have been useful to obtain additional sources of survey coverage data and explore country-specific correlates of complete HBV vaccination in more detail. Nevertheless, the DHS are carefully planned surveys thatemploy rigorous methodology, which adds to the validity of the study’s findings. Overall, while the limitations should be considered when interpreting the results, our study provides valuable insights into the prevalence and sociodemographic and healthcare correlates of childhood HBV vaccination coverage in the three countries examined.
Conclusion
In summary, we found suboptimal levels of HBV vaccination coverage among children in Sierra Leone, Liberia, and Guinea. Within countries, vaccination coverage varied based on sociodemographic characteristics and healthcare access factors. Being a male child, Muslim mothers, low household wealth index, low antenatal clinic attendance, home delivery, and proximity to health facilities were important determinants of incomplete HBV vaccination. These findings underscore the critical need to address socioeconomic and healthcare inequities that are contributing to suboptimal HBV vaccination uptake and stalling progress towards achieving the 2030 global viral hepatitis elimination targets in these endemic countries.
Supplementary material
The supplementary material for this article can be found at http://doi.org/10.1017/S0950268823001735.
Data availability statement
The data that support the findings of this study are available from the Demographic and Health Surveys (DHS) Programme (https://dhsprogram.com/). Restrictions apply to the availability of these data, which were used under licence for this study.
Author contribution
Conceptualization, G.A.Y., P.B.J., and R.A.S.; methodology, G.A.Y., P.B.J., A.M.M., U.B., S.P.E.M., S.A.Y., M.G., A.J., L.S.B., S.L., and R.A.S.; resources, G.A.Y. and R.A.S.; software, G.A.Y.; statistical analysis, G.A.Y.; interpretation of results, all authors; writing—original draft preparation, G.A.Y., P.B.J., A.M.M., U.B., S.P.E.M. and R.A.S.; writing—review and editing, all authors. All authors contributed to important intellectual content and have read and agreed to the final version of the manuscript.
Financial support
G.A.Y. was supported by grants from the National Institutes of Health/AIDS Clinical Trials Group under Award Number AI068636 (1560GYD212), the Roe Green Center for Travel Medicine and Global Health/University Hospitals Cleveland Medical Center Award Number J0713 and the University Hospitals Minority Faculty Career Development Award/University Hospitals Cleveland Medical Center Award Number P0603. A.M.M. was supported by the National Institute for Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) (grant K01AI166126). The funders had no role in the design or authorship of this publication. Article contents are solely the responsibility of the authors and do not necessarily represent the official views of the funders.
Competing interest
The authors declare no competing interests exist.
Ethical standard
The protocols for the DHS methodology and data collection procedures were approved by the institutional review boards or ethics committees at ICF Macro, the Sierra Leone Ethics and Scientific Review Committee, the University of Liberia Pacific Institute for Research and Evaluation, and the Guinea National Ethics Committee for Health Research (Comité National d’Ethique pour la Recherche en Santé). Written permission to use the respective country datasets was granted by DHS.
Open access
